Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD8848 in seasonal allergic rhinitis
NCT01185080Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd-8848 in allergic rhinitis (AR), sponsored by AstraZeneca. Started Sep 2010; status: completed.
02
Drugs
azd-8848
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01185080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185080.